Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Pfizer announces Viagra market introduction

April 16, 1998

Propionanilide derivatives for lipoprotein disorders discovered at Yamanouchi

April 16, 1998

Yamanouchi describes novel antidiabetic agents

April 15, 1998

Neurogen evaluates benzylamine derivatives as NPY receptor ligands

April 15, 1998

FDA approves fifth indication for Neupogen

April 14, 1998

Novartis presents new tyrosine kinase inhibitor with antiresorptive activity

April 14, 1998

Orphan Medical receives approval to market Sucraid in U.S.

April 14, 1998

FDA advisory committee will meet to discuss Ergoset NDA

April 14, 1998

OSI Pharmaceuticals and Hoechst Marion Roussel extend EPO collaboration

April 14, 1998

Overview of preclinical and clinical data for rHuMGDF

April 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...